Profile for Austria Patent: E462409
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Austria Patent: E462409
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,912,772 | Jul 26, 2032 | Braeburn | BRIXADI | buprenorphine |
| 11,110,084 | Jul 26, 2032 | Braeburn | BRIXADI | buprenorphine |
| 11,135,215 | Jul 26, 2032 | Braeburn | BRIXADI | buprenorphine |
| 12,161,640 | Jul 26, 2032 | Braeburn | BRIXADI | buprenorphine |
| 12,318,379 | Jul 26, 2032 | Braeburn | BRIXADI | buprenorphine |
| 8,236,292 | Jan 10, 2027 | Braeburn | BRIXADI | buprenorphine |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
